Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
tianyizy.com

See what CB Insights has to offer

Investors Count

1

Deal Terms

1

Liaoning TianYi Biological Pharma Funding, Liaoning TianYi Biological Pharma Valuation & Liaoning TianYi Biological Pharma Revenue

1 Fundings

Liaoning TianYi Biological Pharma's latest funding round was a Acquired for on December 4, 2015.

Liaoning TianYi Biological Pharma's latest post-money valuation is from December 2015.

Sign up for a free 30-day trial to see Liaoning TianYi Biological Pharma's valuations in December 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/4/2015

Acquired

$99M

$0.00B

((9.99x))

FY 1234

1

Date

12/4/2015

Round

Acquired

Amount

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

Liaoning TianYi Biological Pharma Deal Terms

1 Deal Term

Liaoning TianYi Biological Pharma's deal structure is available for 1 funding round, including their Acquired from December 04, 2015.

Round

Acquired

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

Liaoning TianYi Biological Pharma Investors

1 Investors

Liaoning TianYi Biological Pharma has 1 investors. Eisai invested in Liaoning TianYi Biological Pharma's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/4/2015

12/4/2015

1
Acquired

Corporation

Japan

First funding

12/4/2015

Last Funding

12/4/2015

Investor

Rounds

1
Acquired

Board Seats

Type

Corporation

Location

Japan

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.